Evaluation of Microcirculation of Peripheral Vascular Disease in Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03528811|
Recruitment Status : Unknown
Verified May 2018 by Maoquan Li, Shanghai 10th People's Hospital.
Recruitment status was: Recruiting
First Posted : May 18, 2018
Last Update Posted : May 18, 2018
|Condition or disease||Intervention/treatment||Phase|
|Peripheral Vascular Disease in Diabetes||Diagnostic Test: Five points test of Tongji university||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||300 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Evaluation of Microcirculation of Peripheral Vascular Disease in Diabetes|
|Actual Study Start Date :||August 1, 2016|
|Estimated Primary Completion Date :||July 31, 2018|
|Estimated Study Completion Date :||July 31, 2018|
Five points test of Tongji university
We established the evaluatation and follow-up system of diabetes vascular disease based on the method called "Five points test of Tongji university" .
Diagnostic Test: Five points test of Tongji university
In each group, we will evaluate the microcirculation of diabetic foot using the newly-established "Five points test of Tongji university" before or after the operation, and then compare the temperature of the five points with the other data.
- Coincidence rate of "5 points test of Tongji university" [ Time Frame: 12 months ]The primary study endpoint was that the coincidence rate of evaluating the microcirculation by the newly-established "5 points test of Tongji university" attains over 95% before and after operations as assessed by digital substraction angiography (DSA).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03528811
|Contact: Maoquan Li, Ph.Dfirstname.lastname@example.org|
|Shanghai Tenth People's Hospital, Tong ji University||Recruiting|
|Contact: Mao Q Li, Ph.D 02166313506 email@example.com|
|Study Director:||Xue Li, Ph.D||Shanghai 10th People's Hospital|